2026-08-03T11:15:18-05:00 2025-12-31 521186096 RUBINO AND COMPANY CHARTERED 6903 ROCKLEDGE DRIVE SUITE 300 BETHESDA MD 208171818 990 2025-01-01 521694732 SOCIETY FOR WOMEN'S HEALTH RESEARCH SOCI 2022238224 1025 CONNECTICUT AVE NW 1104 WASHINGTON DC 20036 KATHRYN SCHUBERT PRESIDENT & CEO 2022238224 2026-08-03 1 KAY VOLLANS CPA P01404047 3015643636 2025 2025-03-06 01:10:19Z KATHRYN SCHUBERT 1025 CONNECTICUT AVE NW 1104 WASHINGTON DC 20036 3986489 0 X WWW.SWHR.ORG X 1990 DC TO IMPROVE THE HEALTH OF WOMEN THROUGH SCIENCE, POLICY, AND EDUCATION. 12 12 13 12 0 0 2540492 2401602 0 0 128360 101025 -142228 -155887 2526624 2346740 0 0 0 0 1553495 1766131 0 0 121583 816678 525088 2370173 2291219 156451 55521 3693359 3683123 481004 270708 3212355 3412415 ADVANCE WOMEN'S HEALTH THROUGH SCIENCE, POLICY, AND EDUCATION WHILE PROMOTING RESEARCH ON SEX DIFFERENCES TO OPTIMIZE WOMEN'S HEALTH. 0 0 895169 SCIENTIFIC, SWHR NETWORKS, AND BOSD JOURNAL - SWHR MAINTAINS A DIALOGUE WITH THE PUBLIC AND PRIVATE SECTOR RESEARCH COMMUNITIES TO EDUCATE THEM ABOUT THE NEED FOR RESEARCH IN WOMEN'S HEALTH AND THE STUDY OF SEX DIFFERENCES. SWHR CO-OWNS THE BIOLOGY OF SEX DIFFERENCE JOURNAL (TO ENHANCE THE KNOWLEDGE OF SEX AND GENDER DIFFERENCES). SWHR CONVENES INTERDISCIPLINARY WORKING GROUP MEMBERS THAT INCLUDE RESEARCHERS, CLINICIANS, PATIENTS, AND OTHER EXPERTS TO ADDRESS GAPS IN KNOWLEDGE AND UNMET NEEDS IN WOMEN'S HEALTH ACROSS THE LIFESPAN. 794803 POLICY AND ADVOCACY - SWHR SEEKS TO INCREASE FEDERAL FUNDING FOR BIOMEDICAL RESEARCH FOR CONDITIONS THAT AFFECT WOMEN AND FOR SEX DIFFERENCES RESEARCH. SWHR SEEKS TO ENSURE THAT WOMEN ARE INCLUDED APPROPRIATELY IN CLINICAL TRIALS, THAT TRIAL RESULTS (RESEARCH FINDINGS) ARE ANALYZED FOR SEX AND GENDER DIFFERENCES, AND THAT APPROPRIATE FUNDING IS PROVIDED FOR THE OFFICES OF WOMEN'S HEALTH AT NIH, HHS, AND FDA. FURTHERMORE, SWHR ADVOCATES FOR IMPROVED REGULATORY POLICY, COVERAGE AND PAYMENT POLICY, AND PRIVATE HEALTH PLAN POLICY TO BENEFIT THE HEALTH OF WOMEN. 157488 COMMUNICATIONS - SWHR EDUCATES WOMEN IN THE PUBLIC ABOUT THE VALUE OF BIOMEDICAL RESEARCH AND THE LATEST FINDINGS ABOUT DISEASE PREVENTION, DIAGNOSIS, AND TREATMENT OPTIONS. 1847460 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 13 0 1 13 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 DC X YONAS FSAHAYE 2022238224 1025 CONNECTICUT AVE NW 1104 WASHINGTON DC 20036 KATHRYN SCHUBERT MPP CAE PRESIDENT & CEO 37.50 X 355497 0 63875 YONAS FSAHAYE MBA CFO 37.50 X 190574 0 18466 IRENE O ANINYE CHIEF SCIENCE OFFICER 37.50 X 176495 0 21088 LINDSEY N MILTENBERGER CHIEF ADVOCACY OFFICER 37.50 X 160028 0 22992 JULIE MILLER DEVELOPMENT DIRECTOR 37.50 X 115351 0 44986 ERIKA MILLER JD BOARD CHAIR 3.00 X X 0 0 0 PATTI COMPTON MS EXECUTIVE COMMITTEE DIRECTOR 3.00 X X 0 0 0 JENELLE KRISHNAMOORTHY PHD SECRETARY-TREASURER 3.00 X X 0 0 0 SHONTELLE DODSON PHARMD IMMEDIATE PAST CHAIR 3.00 X X 0 0 0 GRETTA STONE IMMEDIATE PAST CHAIR 3.00 X X 0 0 0 JIM CAREY DIRECTOR 3.00 X 0 0 0 ANNE B CROPP PHARMD BCAP DIRECTOR 3.00 X 0 0 0 LINDA G GRIFFITH PHD DIRECTOR 3.00 X 0 0 0 SHYAM KOTTILIL PHD DIRECTOR 3.00 X 0 0 0 JUDETTE LOUIS MD MPH DIRECTOR 3.00 X 0 0 0 MARIANNE SLIGHT DIRECTOR 3.00 X 0 0 0 MICHAEL YBARRA MD DIRECTOR 3.00 X 0 0 0 997945 0 171407 5 0 1 0 0 370000 460000 1571602 2401602 123267 123267 1461620 1483862 -22242 -22242 -22242 0 460000 155887 -155887 -155887 2346740 0 0 -54862 634115 538998 95117 851271 649202 121506 80563 155003 119427 21975 13601 125742 118206 278 7258 1903 1903 20949 20949 13035 13035 156182 156182 17643 2790 12650 2203 195745 158509 27769 9467 29714 28342 1266 106 59494 54384 3751 1359 7654 5297 1977 380 SUBSCRIPTIONS 22517 15871 6646 LICENSES & FEES 252 252 2291219 1847460 322176 121583 69025 133193 356776 669862 225000 0 60 0 30245 31576 73303 35016 42674 38287 2708570 2678013 261009 132192 3693359 3683123 37626 44357 175000 100000 268378 126351 481004 270708 X 2299982 2326715 912373 1085700 3212355 3412415 3693359 3683123 55521 144539 0 X X 0 1 X 1 0 X 2158435 1980941 2470544 2540492 2401602 11552014 2158435 1980941 2470544 2540492 2401602 11552014 3680808 7871206 37205 53831 46155 86122 123267 346580 11898594 0.66150 0.65070 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 18803 8327 10476 54500 26689 27811 38287 OPERATING LEASE LIABILITY 126351 126351 X 2478244 144539 144539 2333705 13035 13035 2346740 2278184 0 2278184 13035 13035 2291219 PART X, LINE 2: SWHR IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES (EXCEPT TAXES ON UNRELATED BUSINESS INCOME) UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED BY THE INTERNAL REVENUE SERVICE AS OTHER THAN A PRIVATE FOUNDATION. NO PROVISION FOR INCOME TAXES IS REQUIRED FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 SINCE SWHR HAD NO TAXABLE INCOME FROM UNRELATED BUSINESS ACTIVITIES. THE INCOME TAX POSITIONS TAKEN BY SWHR FOR ANY YEARS OPEN UNDER THE VARIOUS STATUTES OF LIMITATIONS ARE THAT SWHR CONTINUES TO BE EXEMPT FROM INCOME TAXES AND THAT THEY HAVE PROPERLY REPORTED UNRELATED BUSINESS INCOME THAT IS SUBJECT TO INCOME TAXES. SWHR BELIEVES THAT THERE ARE NO TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD SIGNIFICANTLY INCREASE UNRECOGNIZED TAX LIABILITIES WITHIN 12 MONTHS OF THE REPORTING DATE. NONE OF SWHR'S FEDERAL OR STATE INCOME TAX RETURNS ARE CURRENTLY UNDER EXAMINATION. GALA EVENT 460000 460000 511 5000 81264 20364 48748 460000 460000 511 5000 81264 20364 48748 155887 -155887 X X X 0 0 0 0 0 0 0 1 0 KATHRYN SCHUBERT MPP CAE PRESIDENT & CEO 301497 0 54000 0 0 0 31500 0 32375 0 419372 0 0 0 YONAS FSAHAYE MBA CFO 173249 0 17325 0 0 0 17152 0 1314 0 209040 0 0 0 IRENE O ANINYE CHIEF SCIENCE OFFICER 140667 0 35828 0 0 0 13346 0 7742 0 197583 0 0 0 LINDSEY N MILTENBERGER CHIEF ADVOCACY OFFICER 157528 0 2500 0 0 0 14787 0 8205 0 183020 0 0 0 JULIE MILLER DEVELOPMENT DIRECTOR 112851 0 2500 0 0 0 6246 0 38740 0 160337 0 0 0 PART I, LINE 7 THE BONUS AWARDED TO THE CEO WAS APPROVED BY THE BOARD OF DIRECTORS. BONUSES FOR ALL OTHER STAFF WERE APPROVED BY THE CEO IN ACCORDANCE WITH THE BOARD-APPROVED COMPENSATION POLICIES. FORM 990, PART VI, SECTION B, LINE 11B THE DRAFT IRS FORM 990 IS SHARED VIA EMAIL WITH THE BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE MEETS VIRTUALLY TO REVIEW THE FORM BEFORE THE CHIEF EXECUTIVE OFFICER SIGNS IT. THE EXECUTIVE COMMITTEE WILL INCLUDE A SUMMARY OF THIS REVIEW IN ITS NEXT REPORT TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C SWHR'S CONFLICT OF INTEREST STATEMENT IS SENT ANNUALLY TO EACH BOARD MEMBER (VIA EMAIL AND MAIL) WITH A REQUEST THAT EACH MEMBER SIGN AND RETURN IT. STAFF FOLLOW UP TO ENSURE THAT ALL BOARD MEMBERS SIGN THE DOCUMENT BEFORE THE FIRST MEETING OF THE BOARD EACH YEAR. AT THAT MEETING, ANY MEMBERS WHO HAVE NOT SIGNED ALREADY ARE GIVEN AN OPPORTUNITY TO SIGN IT. ANY BOARD MEMBER WHO REFUSES TO SIGN THE STATEMENT IS ASKED TO RESIGN FROM THE BOARD. FORM 990, PART VI, SECTION B, LINE 15A THE CEO'S PERFORMANCE IS REVIEWED ANNUALLY BY SWHR'S EXECUTIVE COMMITTEE PRIOR TO THE ANNIVERSARY DATE OF THE CEO'S CONTRACT BASED UPON PERFORMANCE CRITERIA AND GOALS PROVIDED IN WRITING TO THE CEO AT THE BEGINNING OF THE PERIOD UNDER REVIEW. THE EXECUTIVE COMMITTEE USES DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS IN MAKING DECISIONS ABOUT ANY RAISES IN COMPENSATION FOR THE CEO. ANY MEMBERS OF THE EXECUTIVE COMMITTEE WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENTS ARE NOT INVOLVED IN THE REVIEW AND APPROVAL. A SUMMARY OF THE ACTIONS TAKEN BY THE EXECUTIVE COMMITTEE IS PRESENTED BY THE COMMITTEE CHAIR TO AN EXECUTIVE SESSION OF THE BOARD. THE SUMMARY INCLUDES: 1. THE COMMITTEE MEMBERS PRESENT DURING THE DISCUSSION AND THOSE WHO VOTED ON IT, 2. THE COMPARABILITY DATA USED AND HOW IT WAS OBTAINED, 3. THE TERMS AND DATE OF THE APPROVED COMPENSATION, AND 4. THE RATIONALE FOR DETERMINING WHY EXECUTIVE COMPENSATION MIGHT EXCEED THAT OF A COMPARABLE ORGANIZATION OR MARKET. ALL OTHER STAFF ARE REVIEWED BY THE ORGANIZATION'S CEO AND/OR DIRECT SUPERVISORS, WITH ULTIMATE APPROVAL OF REVIEWS BY THE CEO. STAFF REVIEWS CONSIST OF VERBAL FEEDBACK, MEETINGS WITH THEIR SUPERVISORS, AND WRITTEN SUPERVISOR COMMENTS. COMPENSATION DECISIONS ARE BASED ON THE REVIEWS AND COMPARABILITY DATA FROM SIMILAR ORGANIZATIONS. FORM 990, PART VI, SECTION C, LINE 19 SWHR'S GOVERNING DOCUMENTS AND BOARD POLICIES, INCLUDING THE CONFLICT OF INTEREST POLICY, ARE POSTED ON SWHR'S WEBSITE. FINANCIAL STATEMENTS AND 990 ARE AVAILABLE UPON REQUEST AND CAN BE SENT VIA HARD COPY MAIL OR E-MAIL. THE FINANCIALS AND 990 ARE ALSO AVAILABLE ON VARIOUS CHARITY WEBSITES FOR PUBLIC REVIEW. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR